Legacy Education (LGCY) Q2 2026 earnings review
Enrollment Boom Drives 62% EBITDA Surge
Legacy Education delivered a standout quarter with Revenue up 40.7% and Adjusted EBITDA jumping 61.6% YoY. The growth engine is firing on all cylinders: new student starts accelerated to +49% YoY, driving total enrollment up nearly 17%. Despite significant increases in marketing and staffing costs to support this volume, the company demonstrated strong operating leverage, expanding margins. While sequential revenue flattened (-1% vs Q1) due to expected holiday seasonality, the year-over-year trajectory confirms the growth thesis is intact.
🐂 Bull Case
New student starts grew 49.4% YoY to 593. This represents a significant acceleration from the 3% growth seen in the prior year period (25Q2). This 'top of funnel' metric is the leading indicator for revenue over the next 12-18 months.
Expenses are rising, but revenue is rising faster. Revenue grew 40.7% while Adjusted EBITDA grew 61.6%, indicating that the fixed cost base of campuses is being utilized more efficiently as enrollment density increases.
🐻 Bear Case
General & Administrative expenses rose 40.4%, matching revenue growth. Management cited increased marketing and professional fees. If customer acquisition costs (CAC) are rising to chase growth, margins could compress if enrollment velocity slows.
The earnings release explicitly flagged an increase in 'bad debt expense' as a primary driver for the jump in G&A. With a student population increasingly reliant on financing, credit quality remains a key risk to monitor.
⚖️ Verdict: 🟢
Bullish. The 49% surge in student starts validates the demand for healthcare education. While cost discipline (particularly G&A) needs watching, the company is successfully converting top-line volume into bottom-line margin expansion.
Key Themes
Accelerating Enrollment Velocity
The core growth story is strengthening. New student starts accelerated significantly this quarter. In 25Q2, starts grew only 3% YoY; in 26Q2, they surged 49.4%. This intake drove total student population to 3,234 (+16.8%), providing high visibility for tuition revenue in the second half of FY26.
Rising Bad Debt and Marketing Costs
G&A expenses ballooned to $6.1M (+40.4% YoY). Of this, $3.0M was marketing expense (up from $2.3M). More concerning is the explicit mention of 'bad debt expense' contributing to the rise. In 26Q1, the company took a specific AR reserve; the continuation of this theme suggests payment collections from students require scrutiny.
Profitable Scaling
Despite the cost pressures, the unit economics are working. Net Income rose 46% to $2.0M, and Diluted EPS hit $0.15 (+50%). The company is proving it can scale its campus footprint and program offerings (adding MRI, Cardiac Sonography) while maintaining profitability.
Instructional Cost Inflation
Educational services expense rose 37.6% to $10.3M. While lower than revenue growth (positive leverage), the press release attributes this to 'increased instructional and staffing' and 'non-cash compensation.' As the company adds specialized programs like Surgical Tech and Cardiac Sonography, the cost of qualified instructors is a structural headwind.
Other KPIs
Stable. Margin improved significantly from 13.7% in the prior year (25Q2) but remained flat sequentially vs 26Q1 (15.9%), reflecting typical Q2 seasonality. The YoY expansion demonstrates the scalability of the model.
Strong. Cash increased slightly from $20.6M in Sep 2025. With only ~$0.7M in debt, the balance sheet remains pristine, providing dry powder for further M&A or campus expansion.
Accelerating. Up 16.8% YoY. This is a critical forward-looking metric as these students will recognize revenue over upcoming quarters.
Guidance
Management did not provide specific numeric guidance ranges in the release. The CEO stated: 'We believe the momentum we are seeing positions us well for continued growth.' Given the 39.6% revenue growth in H1 FY26, the company is on track to significantly exceed FY25 totals.
Key Questions
Bad Debt Specifics
G&A expense was driven up by 'bad debt.' What is the specific dollar amount of the bad debt provision in Q2, and is this related to a specific cohort or program?
Marketing Efficiency
Marketing spend increased ~30% ($2.3M to $3.0M) while new starts increased 49%. This implies improved efficiency (lower CAC). Is this sustainable, or was Q2 aided by specific one-time campaigns?
M&A Pipeline
With $21M in cash and a clean balance sheet, what is the status of the 'multi-campus' acquisition targets mentioned in the Q1 call?